Immunogenes Ltd. elaborated a patentable method to create transgenic animals producing policlonal and monoclonal antibodies to be used in therapies, diagnostics and research.
The product serves to treat everyday anxiety effectively and harmlessly without side effects. Anxiety is a problem affecting 20% of the population in the developed countries.